*UPDATE 2/25/22*
HB5637 has now been referred to the Senate Health Policy and Human Services Committee. Continue contacting your Senators as well as Committee members urging them to support this bill!
*UPDATE 2/24/22*
HB5637 has passed through the House and is now headed to the Senate. Contact your Senators today and urge them to support this bill!
A bill to amend 2014 Public Act 345, entitled the "Right to Try Act", by amending Section 1 (MCL 333.26451).
HB5637 amends the Right to Try Act by adding the following to Section 1 of PA 345:
During a COVID-19 pandemic emergency, investigational drug, biological product, or device also includes both of the following: (i) A drug, biological product, device, or other treatment, that remains under investigation in a United States Food and Drug Administration-approved clinical trial and that a physician recommends as a remedy for coronavirus disease 2019. (ii) A drug, biological product, or device normally prescribed as a remedy to treat an illness other than coronavirus disease 2019 that a physician recommends as a remedy for coronavirus disease 2019.
This bill is due to be read in the House Health Policy Committee on January 27, 2022.
Contact your legislators and urge them to support this bill!
Comments